Shock Pathophysiology, Classification, and Approach to Management.
Shock - Pathophysiology, Clinical Features & Management
-
Upload
ankit-sharma -
Category
Health & Medicine
-
view
1.225 -
download
3
Transcript of Shock - Pathophysiology, Clinical Features & Management
SHOCKPATHOPHYSIOLOGYCLINICAL FEATURESMANAGEMENT
DR ANKIT SHARMADR ARUN KUMAR M
1
2
SAMUEL V GROSS, 1872 “Shock is the manifestation of the rude unhinging of the machinery of life”
HISTORICAL PERSPECTIVE• Ambroise Paré (1510) – Fluids to injured patients• ‘Shock’ – 1743 – act of impact/ collision• Guthrie (1815) – described physiological instability• Crile (1899) – Importance of measuring BP• Claude Bernard – Milieu intérieur• Walter B. Cannon – Homeostasis• WW I – Disturbance of nervous system• Alfred Blalock (1934) – 4 categories of shock• Carl John Wiggers (1950) – Wiggers prep
3
Definition A systemic state of tissue hypo-perfusion, which is inadequate for normal cellular respiration
Systemic – global phenomenonHypoperfusion (relative/ absolute)Inadequate cellular respiration Anaerobic, dysfunctionBody responses thereof
4
Types• Hypovolemic• Cardiogenic• Septic (vasogenic)• Neurogenic• Traumatic• Obstructive
5
Hypovolemic shock• Hemorrhagic• Trauma• Bleeding disorders• GI/ GU bleed
• Non- hemorrhagic • Dehydration• “Inter compartmental fluid mal-adjustments”• Third spacing
6
Cardiogenic Shock• Pump failure
• Adequate but ineffective intravascular volume. • Cardiac causes • Pulmonary embolism
• High mortality rates
8
Cardiogenic shock• Hemodynamic criteria: 1. Sustained Hypotension (i.e. SBP <90 mm Hg for at least 30 minutes)
2. Reduced Cardiac Index (<2.2 L/min per square meter) &
3. Elevated Pulmonary Artery Wedge Pressure (>15 mm Hg)
9
SEPTIC SHOCK• Four sepsis-related clinical syndromes = Four steps of increasingly exaggerated systemic inflammatory responses
SIRSSepsis Severe Sepsis (Sepsis Syndrome) Septic Shock
11
DEFINITIONS DESCRIBING THE CONDITION OF SEPTIC PATIENTS
Bacteremia: Bacteria in blood Positive blood cultures
Septicemia: Microbes or their toxins in blood
12
DEFINITIONS DESCRIBING THE CONDITION OF SEPTIC PATIENTS
SIRS: Two or more of the following (1) Temperature >38°C or <36°C (2) Heart Rate > 90/ min (3) Respi rate > 24/ min (4) TLC >12,000/mm3 or <4,000/mm3)
or >10% bands on PBS◦ SIRS may have a noninfectious etiology
Sepsis: SIRS that has a proven/ suspected microbial etiology13
DEFINITIONS DESCRIBING THE CONDITION OF SEPTIC PATIENTS
Severe Sepsis (Similar to sepsis syndr): Sepsis with one or more signs of organ dysfunction:
1. Cardiovascular
2. Renal
3. Respiratory
4. Hematologic
5. Unexplained metabolic acidosis
6. Adequate fluid resuscitation14
DEFINITIONS DESCRIBING THE CONDITION OF SEPTIC PATIENTS Septic Shock: Sepsis + Hypotension
or Need for vasopressors to
maintain systolic BP 90 mmHg or MAP70 mmHg
15
DEFINITIONS DESCRIBING THE CONDITION OF SEPTIC PATIENTS
Refractory septic shock: Septic shock
◦ lasting for >1 h ◦ Not responding to fluid or pressor administration
MODS: Dysfunction of more than one organ system, requiring intervention (individual organ support) to maintain homeostasis
16
NEUROGENIC SHOCK• Acute loss of sympathetic vascular tone• Loss of vascular resistance
◦ Pooling in capacitance vessels◦ Reduced preload◦ Poor cardiac output◦ Inadequate pressure in arterial system to maintain
capillary perfusion
17
NEUROGENIC SHOCK Etiology:
◦ High cervical spinal cord injury (vertebral body #)◦ inadvertent cephalad migration of spinal anaesthesia◦ epidural hematoma or devastating head injury
Failure of fluid resuscitation to improve hemodynamics, where no source of blood loss or sepsis can be identified
Vasopressors are necessary to treat this condition
18
TRAUMATIC SHOCK• Hemorrhage overtly controlled, but patients continues to lose plasma volume into the interstitium • Secondary microcirculatory injury• Excessive pro-inflammatory response• Third spacing
19
OBSTRUCTIVE SHOCK• Reduction in preload due to mechanical obstruction of cardiac filling
•Common causes: cardiac tamponade, tension pneumothorax, massive pulmonary embolus or air embolus
20
PATHOPHYSIOLOGY OF SHOCK• Initial response driven by • Tissue hypoperfusion • Developing cellular energy deficit.
• Demand-supply mismatch • Neuro-endocrine & inflammatory response (proportional
to degree & duration of shock)
• The specific responses depends on etiology of shock
21
22SHOCK INDUCED VICIOUS CYCLE
CELLULAR PATHOPHYSIOLOGY• Compensation/ Dysfunction/ Death
23
↓ O2 concn in cells
↓
↓ oxidative phosphorylation
↓
↓ ATP synthesis
↓
shift from aerobic to anaerobic glycolysis
↓
Pyruvate converted to lactate
↓
accumulation of lactate & inorganic phosphate, thus ↓ pH
↓
intracellular metabolic acidosis lactate & other wastes exit cells ↓
systemic metabolic acidosis
25
MICROVASCULAR PATHOPHYSIOLOGY• α1 receptors – vasoconstriction • ẞ2 receptors - vasodilation.• Shock norepinephrine & epinephrine from adrenal medulla → α1 receptors• Other constrictors: A-II, vasopressin, endothelin 1, and TxA2• Vasodilators: PG I2, NO and adenosine
28
29
Hypoxia & acidosis
↓
Complement & neutrophil activation
↓
Free radical & cytokine release
↓
Injury to capillary endothelial cells
↓
Further activation of immune & coagulation systems
↓
Damage to endothelium with loss of integrity
↓
Leaky capillary endothelium
↓
Tissue edema & cellular hypoxia
30
CARDIOVASCULARPATHOPHYSIOLOGY
Shock
↓
↓ Preload & ↓ Afterload
↓
↑ sympathetic output
↓
catecholamine release from adrenal medulla
↓
↑ heart rate & contractilityvenous and arterial vasoconstriction (Except in sepsis)
31
• Arterial vasoconstriction with regional variations • Shunting of blood away from less essential organ beds such as the intestine, kidney, and skin • Brain & heart – autoregulatory mechanisms
CARDIOVASCULARPATHOPHYSIOLOGY
PULMONARY PATHOPHYSIOLOGY• Tachypnea• ↑ minute ventilation & ↑ CO2 excretion• Compensatory respiratory alkalosis• Resuscitation induced O2 free radical injury• ALI & ARDS• Non cardiogenic pulmonary edema
32
RENAL PATHOPHYSIOLOGY• Decreased renal blood flow• RAS activation• ↓ GFR + ↑ aldosterone & vasopressin → Oliguria
• Further vasoconstriction → ↑ sodium & water retention → edema
• Toxic tubular injury & Tubular obstruction
33
ENDOCRINE PATHOPHYSIOLOGY• Na+ & water retention K+ & H+ lost• Hypovolaemia ADH• Adrenergic drive Norepinephrine release•Vasoconstriction•↑ glycogenolysis & ↑ gluconeogenesis•↓ Insulin release
34
35
CRH (Hypothalamus)
↓
ACTH (pituitary)
↓
Cortisol (Adrenal Cortex)
↓
Cortisol + Epinephrine + Glucagon Catabolic state↓
Gluconeogenesis & Insulin resistance
↓
Hyperglycemia, Muscle protein break down, lipolysis
ENDOCRINE PATHOPHYSIOLOGY
METABOLIC DERANGEMENTS• Disruption of C-P-L metabolism• Anaerobic metabolism Lactate• ↑ Hepatic gluconeogenesis• Hepatic lipogenesis ↑ TG• Protein catabolism → muscle wasting
36
37
INFLAMMATORY & IMMUNE RESPONSE
Pro-inflammatory Anti-inflammatoryIL-1α/ẞ IL-4
IL-2 IL-10IL-6 IL-13IL-8 IL-1Ra
IFN-ϒ PGE2
TNF-α TGF-βPAF
TNFR- I/II
INFLAMMATORY & IMMUNE RESPONSE• MODS• Counter-regulatory immune response• Delayed MOF
38
SEPTIC SHOCK• Culture proven etiology +/-• Any class of micro-organism • Gram (-) ve bacteria > Gram (+) ve bacteria > polymicrobial infection > fungi • Gm (-) ve bacteria = Enterobacteriaceae, pseudomonads, Haemophilus etc. •Gm (+) ve bacteria = S.aureus, coagulase (-) ve staph, enterococci, S.pneumoniae etc.
40
SEPTIC SHOCKMyocardial depression
+ Hypovolemia
+ other factors
↓
Tissue hypoxia (hypodynamic pd)
↓
↑ blood lactate & ↓ central venous O2 saturation
41
SEPTIC SHOCKAfter fluid administration
↓ ↓ peripheral vascular resistance
(vasodilatory phase) Hallmark of septic shock
42
45
Clinical Features & Management
46
Severity of shockCompensated shock
Decompensation• Mild shock
• Moderate shock• Severe shock
Unresuscitable Shock
MOF
47
Severity of shock Compensated shock
◦ Loss of up to 15% of circulatory volume
◦ Maintain central blood volume
◦ If prolonged (>12 hrs) Ischaemia-Reperfusion effect
48
Severity of shock Decompensation
◦ Loss of > 15% of circulating volume.
◦ Progressive Renal, Respiratory & Cardiovascular decompensation.
◦ Hypotension >30-40% volume loss.
49
Severity of shock
50
Hemorrhagic shock
51
Hemorrhagic shockMost common cause of shock in the surgical or trauma patients
Young patients vs elderly patients
52
Hemorrhagic shock Classification of hemorrhage
53
Hemorrhagic shockApproach to Hemorrhagic shock
Identify haemorrhage
Immediate resuscitative maneuvers
Identify the site of haemorrhage
Haemorrhage control
Damage control resuscitation
54
Hemorrhagic shockTreatment concurrently with diagnostic evaluation
Time dependent survival
Resuscitative maneuvers
55
Hemorrhagic shockHistoryRoot cause of hemorrhage & its site
Any underlying Pathology
Any co-morbidities/medications
56
Hemorrhagic shockSymptoms & Signs:Agitation, Cold clammy extremitiesTachycardia, HypotensionPallorWeak or absent peripheral pulsesProlonged capillary refill timeSystemic examinationSymptoms specific to site of Hemorrhage
57
Hemorrhagic shockSite specific Symptoms & Signs:
Penetrating wounds / Blunt trauma
Sites that can harbor sufficient extra-vascular volume: Intrathoracic (2-3L/ pleural cavity)IntraabdominalRetroperitoneal# long bones
58
Hemorrhagic shockInvestigations
Hematological & Biochemical Investigations
Lactate levels
Blood grouping & cross matching
Radiological investigations as indicated
59
Hemorrhagic shockDamage control resuscitation
Permissive hypotension
Use of limited crystalloids and blood products
Anticipate and treat coagulopathy
Hypothermia
DCS
60
Hemorrhagic shockFluid therapy
Crystalloid
Hypotonic solutions
61
Hemorrhagic shockFluid therapy : Dynamic Fluid ResponseTo determine shock status
250-500ml bolus over 5-10min
HR, BP & CVP are measured
62
Hemorrhagic shockResponders
• Sustained improvement in CVS status after bolus• No active bleeding, require fluids to attain normal volume status
Transient Responders
• Initial improvement followed by reverting to previous state over 10-20 min• Moderate ongoing fluid losses
Non responders
• No improvement in CVS status following bolus• Severely volume depleted and likely to have ongoing loss( persistent uncontrolled Hemorrhage)
63
Hemorrhagic shockTransfusion of blood and blood products
Coagulation factor-based products
Blood product Aim
PRBC Hb 7-9 gm/dl
Platelets > 50,000/ml
64
Hemorrhagic shock Monitoring of response
◦ Clinical : Conscious level, BP, Urine output◦ ECG◦ Pulse oximetry◦ CVP, Invasive BP monitoring◦ Cardiac output◦ Base deficit & serum lactate
65
Hemorrhagic shock
66
Traumatic shockInitial resuscitation
Control of Hemorrhage
Early stabilization of the fractures, debridement or evacuation of hematoma
67
Septic Shock
68
Septic shock
69
SEPSIS SIX The Sepsis Six is the name given to a bundle of medical therapies designed to reduce the mortality of patients with sepsis.
The Sepsis Six consists of three diagnostic and three therapeutic steps – all to be delivered within one hour of the initial diagnosis of sepsis.
◦ Deliver high-flow oxygen.◦ Take blood cultures.◦ Administer empiric intravenous antibiotics.◦ Measure serum lactate and send full blood count.◦ Start intravenous fluid resuscitation.◦ Commence accurate urine output measurement.
70
Management of severe sepsisInitial Resuscitation and Infection Issues
Hemodynamic Support and Adjunctive Therapy
Supportive Therapy of Severe Sepsis
71
Initial Resuscitation and Infection Issues
A. Initial Resuscitation B. Screening for Sepsis and Performance Improvement C. Diagnosis D. Antimicrobial Therapy E. Source Control F. Infection Prevention
72
A. Initial Resuscitation Resuscitation of patients with sepsis- induced tissue hypoperfusion ◦ defined as hypotension persisting after initial fluid challenge or blood
lactate concentration ≥ 4 mmol/L
EGDT (first 6 hrs of resuscitation) ◦ a) CVP 8–12 mm Hg ◦ b) MAP ≥ 65 mm Hg ◦ c) Urine output ≥ 0.5 mL/kg/hr ◦ d) Scvo2 or Svo2 70% or 65%, respectively
73
B. Screening for Sepsis and Performance ImprovementRoutine screening of seriously ill patients for severe sepsis toincrease the early identification of sepsis allow implementation of early sepsis therapy
Performance improvement efforts to improve patient outcomes and decrease sepsis-related mortality.
74
75
C. DiagnosisCultures Imaging studies1,3 β-d-glucan assay ,mannan and anti-mannan antibody assays
76
D. Antimicrobial TherapyInitial empiric anti-infective therapy Broad spectrum Anti fungals
Reassessed daily for potential de-escalationCombination empiric therapyDuration & De-escalation
77
E. Source ControlIntervention for source control within the first 12 hr of diagnosis.
78
Haemodynamic support & Adjunctive therapyFluid therapyVasopressorsInotropic supportCorticosteroids
79
Haemodynamic support & Adjunctive therapyFluid therapy
CrystalloidsAlbumin
VasopressorsNoradrenalineAdrenalineVasopressinDopamine
Ionotropic agents : Dobutamine
Corticosteroid
80
Supportive therapyBlood products administration
Mechanical ventilation of sepsis
induced ARDS
Sedation, analgesia & neuromuscular
blockade
Glucose control
Renal replacement therapy
DVT prophylaxis
Stress ulcer prophylaxis
Nutrition
Setting goals of care
81
Cardiogenic Shock
82
Cardiogenic shock Causes:
◦ Acute MI (most common)◦ Arrythmia◦ End stage cardiomyopathy◦ Myocarditis◦ Severe myocardial contusion◦ LV outflow obstruction◦ Obstruction to LV filling◦ MR◦ Acute aortic insufficiency◦ Metabolic◦ Drug reactions
83
Cardiogenic shockDiagnosis
ECG & ECHO
CXR
ABG
Cardiac enzymes
Invasive monitoring
84
Cardiogenic shockTreatmentAims of treatment
Adequate oxygenation
Judicious fluid administration
Adequate Analgesia
Correcting electrolyte imbalances
85
Cardiogenic shockTreatment
Ionotropic support (Dopamine/Dobutamine)
Treatment of cause
86
Obstructive Shock
87
Obstructive shock Causes:
◦ Tension Pneumothorax◦ Pericardial Tamponade◦ Pulmonary embolus◦ IVC obstruction [Gravid uterus, DVT, Neoplasm]◦ Increased Intra-thoracic pressure [ Excess end-expiratory pressure, Neoplasm]
88
Obstructive shockDiagnosis
Diagnosis is clinical
Chest X-Ray
Echocardiography
Pericardiocentesis
Treatment of the cause
89
Neurogenic Shock
90
Neurogenic shockCauses
Spinal cord Trauma
Spinal cord Neoplasm
Spinal / Epidural anesthesia
91
Neurogenic shock Diagnosis:
Hypotension with bradycardia
Warm extremities
Motor and sensory deficits
Radiographic evidence of vertebral fracture
92
Neurogenic shockTreatment
Fluid resuscitation
Ionotropic support
Operative attempt to stabilise the vertebral fracture.
93
THANK YOU